Key result
Bio-Medicus centrifugal pump associated with ~40% survival to discharge in refractory postcardiotomy heart failure.
Why the study?
Does the Bio-Medicus centrifugal pump improve survival in patients with refractory postcardiotomy heart failure?
Population
10 patients with postcardiotomy heart failure unresponsive to inotropic drugs and aortic counterpulsation…
Design
Case_series
Follow-up
mean 15 months
Authors
Loading...
May support select refractory postcardiotomy cases; leaves open survival benefit versus medical therapy alone.
Observational (n=10)
Does the Bio-Medicus centrifugal pump improve survival in patients with refractory postcardiotomy heart failure?
The Bio-Medicus centrifugal pump can successfully support a subset of patients with refractory postcardiotomy heart failure, though hemorrhagic and renal complications are common and often fatal.
Paolini et al. (1994) conducted an observational in Postcardiotomy heart failure (n=10). Bio-Medicus centrifugal pump was evaluated on Survival to discharge. Support with the Bio-Medicus centrifugal pump in 10 patients with refractory postcardiotomy heart failure resulted in 60% being weaned from the device and 40% surviving to discharge.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: